The reference molecular approach for RNA viruses: reverse transcription of RNA into cDNA followed by amplification and detection.
Many of the most important infectious threats — influenza, SARS-CoV-2, dengue, chikungunya, enteroviruses — are RNA viruses that cannot be detected by DNA PCR alone. RT-PCR converts their RNA genome into amplifiable cDNA.
Specimen requirements: data to be updated. Please contact ID Labs.
Container information: data to be updated.
Validated target list: data to be updated. Please contact ID Labs for the current configuration.
| Characteristic | Value | Source |
|---|---|---|
| Analytical / clinical performance | Performance characteristics: please contact ID Labs — data to be updated. | ID Labs Validated Performance |
Detection of RNA viruses in respiratory, febrile-illness and CNS syndromes; forms the chemistry behind ID Labs syndromic multiplex panels.
Journal of Clinical Virology (PMC) · 2021
Curated peer-reviewed / authoritative reference. Open the source link for the full text.
Frontiers in Medicine · 2023
Curated peer-reviewed / authoritative reference. Open the source link for the full text.
Targeted amplification of pathogen DNA for sensitive, specific qualitative detection of infectious agents.
Real-time fluorescence-monitored amplification enabling rapid detection and, with appropriate calibration, quantitative measurement of pathogen load.
Panel configuration, specimen logistics and turnaround details on request.
Information on this page is educational and does not replace professional clinical judgment. Performance values are labelled by source (ID Labs Specification / ID Labs Validated Performance / Manufacturer Specification / Published Scientific Evidence). Molecular results must be correlated clinically and, where appropriate, confirmed by culture and phenotypic susceptibility testing.
